Clinical Biomarkers & World CDx Boston is a dedicated platform for drug developers, big and small, to discuss the tangible benefit of biomarker driven precision medicine and diagnostic enabled therapies.
The meeting brings together the who’s who of the biomarker and clinical diagnostics sectors to showcase advances in biomarker development, assaying technology and full-fledged diagnostic platforms. From NGS to multiplexing and liquid biopsies, showcase the real-world impact and provide thought leadership on the adoption of these technologies for more safe, effective and value-based personalized healthcare.
Open the door and develop relationships with the most influential leaders in precision medicine, biomarkers and diagnostics from the biggest, most innovative and under-the-radar drug developers
Demonstrate your thought leadership throughout the development and commercialization of a drug-diagnostic product to an exclusive community of high level decision makers
Be the one to define the commercial conversation, as drug developers scramble to define their strategies to improve market penetration and share in this highly competitive landscape